INVESTOR RELATIONS

 

  • SHARE
Subscribe
Varian to Discuss Agreement to Acquire Cancer Treatment Services International

Tuesday, May 21, 2019
8:00am EST

Listen to the Webcast
Presentation
Press Release
To Access the Call:
Inside the U.S.: 1-877-407-9708 / Outside the U.S.: 1-201-689-8259
Replay:
Inside the U.S.: 1-877-660-6853 / Outside the U.S.: 1-201-612-7415
Use Conference ID 13691221

2019 UBS Global Healthcare Conference

Tuesday, May 21, 2019
9:00am EST

Listen to the Webcast

2019 RBC Capital Markets Global Healthcare Conference

Wednesday, May 22, 2019
9:30am EST

Listen to the Webcast

Investor Information

Recent News
May 20, 2019
Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International

Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (NYSE: VAR) today announced it has entered...

May 16, 2019
Varian Announces Incremental Gross Impact of New Tariffs

Varian (NYSE: VAR) today announced preliminary estimates of the incremental gross impact of new tariffs. Over the past week, the US increased tariffs on certain goods (US List 3), and imposed new...

May 14, 2019
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

At a ceremony in Singapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact...

More news >


Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR